Health and Fitness Health and Fitness
Tue, May 25, 2010
[ 06:15 AM ] - Market Wire
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES FINANCING OF UP TO $16.3 MILLION
[ 06:03 AM ] - Market Wire
Nutra Pharma Announces First Manufacturing Releas .. xin Rx, a Prescription Treatment for Chronic Pain
[ 06:01 AM ] - Market Wire
Teva Announces Launch of Generic Valtrex®
[ 05:45 AM ] - Market Wire
Radient Pharmaceuticals Announces First Quarter 2 .. es Update on Onko-Sure(TM) Product Sales and Mone
[ 05:43 AM ] - Market Wire
STERIS Corporation to Present at Jefferies 2010 Global Life Sciences Conference
[ 05:30 AM ] - Market Wire
NMT Medical Launches Rapid Transport Septal Implant Delivery System in France
[ 05:30 AM ] - Market Wire
InternetArray Inc. Upgrades Listing Status
[ 05:00 AM ] - Market Wire
Alkermes Announces Priority Review by FDA for VIVITROL® for Opioid Dependence
[ 05:00 AM ] - Market Wire
Given Imaging Honored for Contributions to Israeli Innovation
[ 04:35 AM ] - Market Wire
ARIAD Announces Recommendation of Data Monitoring .. Interim Analysis of Phase 3 Succeed Trial of Oral
[ 04:30 AM ] - Market Wire
Cytori to Present at Three Upcoming Investor Conferences
[ 04:30 AM ] - Market Wire
International Stem Cell Corporation Moves International Cornea Development Program Forward
[ 04:30 AM ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Opening of E .. 3 Trial for REOLYSIN(R) in Head and Neck Cancers
[ 04:26 AM ] - Market Wire
Abiomed Reports Updated USpella Results Presented at EuroPCR 2010
[ 04:00 AM ] - Market Wire
Auxilium Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
[ 04:00 AM ] - Market Wire
AlumiFuel Power, Inc. Featured in Two Media Publications
[ 03:30 AM ] - Market Wire
Cypress Bioscience, Inc. to Present at Citi Inves .. ment Research's 2010 Global Healthcare Conference
Mon, May 24, 2010
[ 11:30 PM ] - Market Wire
Biogen Idec comm©more travers le monde la Journ©e mondiale annuelle de la scl©rose en plaques
[ 11:30 PM ] - Market Wire
Biogen Idec Globally celebra la giornata mondiale annuale della Sclerosi Multipla
[ 11:08 PM ] - Market Wire
Pharming submits D180 response for Rhucin MAA to EMA without clock stop
[ 10:45 PM ] - Market Wire
Galapagos achieves milestones in osteoporosis alliance
[ 03:33 PM ] - Market Wire
Levi & Korsinsky, LLP Investigates Possible Breac .. ty by the Board of Odyssey Healthcare Inc. - ODSY
[ 02:51 PM ] - Market Wire
Fresenius Medical Care Reaches Agreement with Bumrungrad International to Acquire Asia Renal Care
[ 02:00 PM ] - Market Wire
Amgen, Novartis, Merck, GlaxoSmithKline and Eli Lilly
[ 01:50 PM ] - Market Wire
Cardiovascular Systems Completes Patient Enrollment in COMPLIANCE 360 Clinical Trial
[ 01:30 PM ] - Market Wire
Celgene Corporation to Present at the 2010 Citi Global Health Care Conference
[ 01:19 PM ] - Market Wire
PPD Sets Record and Distribution Dates for Spin-Off of Furiex Pharmaceuticals
[ 01:02 PM ] - Market Wire
Sun Healthcare Group, Inc. Announces Plan to Sepa .. Property Assets; Adopts a Stockholder Rights Plan
[ 01:00 PM ] - Market Wire
Covidien Announces Revised Presentation Details for Citigroup Global Healthcare Conference
[ 01:00 PM ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. st of Presentation at Citi Health Care Conference

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Health Care Conference


Published on 2010-05-24 13:10:11 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 2010 Citi Global Health Care Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa™ senior management team will present a corporate overview on Thursday, May 27, 2010, at 8:00 AM Eastern time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the companya™s web site at [ www.hgsi.com ].

Contributing Sources